Clinical Trials Logo

Idiopathic Scoliosis clinical trials

View clinical trials related to Idiopathic Scoliosis.

Filter by:

NCT ID: NCT03209752 Completed - Clinical trials for Idiopathic Scoliosis

Prediction of 3D Effect of Brace in Idiopathic Scoliosis Treatment Using EOS Imaging System and "Anatomic Transfer".

EOSTransfert
Start date: May 2016
Phase:
Study type: Observational

In this study, the accuracy of a new numerical method is evaluated for predicting the 3D effect of brace on idiopathic scoliosis. This method results from the combination of several innovative technologies: the EOS imaging system and the anatomical transfer developed by Anatoscope. This is an essential step in validating a digital tool that can be used in routine clinical practice.

NCT ID: NCT03194568 Active, not recruiting - Clinical trials for Idiopathic Scoliosis

Vertebral Body Tethering Outcomes for Pediatric Idiopathic Scoliosis

Start date: July 12, 2017
Phase: N/A
Study type: Interventional

This study will assess whether Anterior Vertebral Tethering is a safe and feasible method of anterior approach surgery for spinal deformity in pediatric idiopathic scoliosis.

NCT ID: NCT03190668 Completed - Clinical trials for Idiopathic Scoliosis

Skeletal Muscle and Adipose Tissue Study

Start date: May 29, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to compare the current standard of care for prophylactic Cefazolin administered every 3 hours intravenously with continuous infusion of Cefazolin during pediatric spinal surgery.

NCT ID: NCT02926404 Terminated - Spondylolisthesis Clinical Trials

UNiD Rods Register

Start date: January 2015
Phase:
Study type: Observational [Patient Registry]

Retro-prospective study allowing inclusion of patients with spinal deformities treated by patient-specific rods (UNiD). This study aims to assess performance, clinical outcomes and safety

NCT ID: NCT02651324 Active, not recruiting - Post-operative Pain Clinical Trials

Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis

Start date: May 2013
Phase: Phase 4
Study type: Interventional

This study hypothesizes that the addition of a low-dose ketamine infusion to usual post-operative pain management will improve pain control as evidenced by an improvement in post-operative pain scores for patients undergoing spinal fusion for idiopathic scoliosis.

NCT ID: NCT02607150 Completed - Clinical trials for Idiopathic Scoliosis

Changes in Cerebral Oxygenation During the Administration of Cell Saver Blood and Allogeneic Blood

Start date: December 2014
Phase: N/A
Study type: Observational

A prospective study designed to evaluate changes in tissue and cerebral oxygenation before and following administration of blood for patients undergoing spinal surgery. Red blood transfusions (autologous and allogeneic) are indicated to improve oxygen delivery to the tissues and hence tissue oxygenation. Despite the presumed efficacy, there are limited data to demonstrate changes in tissue oxygenation with the administration of blood. Furthermore, the administration of both autologous blood from cell saver and allogeneic blood can be associated with both acute and long-term deleterious physiologic effects which may impact the perioperative course. As such, data are needed to clearly delineate the benefits of transfusion during the perioperative period.

NCT ID: NCT02409615 Completed - Clinical trials for Idiopathic Scoliosis

Complementary Therapies in Spinal Fusion Patients

Start date: August 2014
Phase: N/A
Study type: Interventional

In this pilot study, our central hypothesis is that two CAM modalities, hypnosis and healing touch as adjunct therapies to the standard of care, will improve analgesic use for post operative pain. In this pilot study the investigators will randomize 45 adolescents undergoing spinal fusion for idiopathic scoliosis to two test groups: Hypnosis with Pain Management Standard of Care for Post Op Pain, Healing Touch with Pain Management Standard of Care, and a control group (Pain Management Standard of Care only).

NCT ID: NCT02199314 Completed - Clinical trials for Idiopathic Scoliosis

Anesthesia and Motor Evoked Potential (MEP) Recruitment

Start date: March 2013
Phase: N/A
Study type: Interventional

Test the hypothesis to recruit larger motor responses to transcranial stimulation.

NCT ID: NCT02084342 Active, not recruiting - Clinical trials for Idiopathic Scoliosis

Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery

Start date: December 2013
Phase: N/A
Study type: Interventional

Intraoperative administration of tranexamic acid (TXA,T) reduces significantly blood loss and blood transfusion requirements during spinal posterior fusion in adolescents with scoliosis. TXA acts mainly by inhibit the plasminogen activator. Desmopressin (DDAVP ,D) can inhibit the fibrinolytic activity by inducing the release of von Willebrand factor from the endothelial cells. But at the same time, it releases tissue-type plasminogen activator (t-PA), which may cripple its hemostatic effect. The investigators supposed that if the investigators combine TXA with DDAVP in scoliosis correction surgery, the blood loss and the transfusion need would be reduced significantly.

NCT ID: NCT01932424 Completed - Clinical trials for Idiopathic Scoliosis

Blood Propofol Concentrations in Children During Spinal Surgery

Start date: January 2013
Phase: Phase 4
Study type: Interventional

During major spinal surgery evoked potential monitoring is performed to detect spinal cord damage. Intra-venous anaesthesia is the preferred anaesthetic technique because volatile anaesthetic agents supress the evoked potentials. Total Intra-Venous Anaesthesia (TIVA) with propofol is commonly administered as a Target Controlled Infusion (TCI). The TCI is an automated drug delivery system which administers propofol to achieve a desired blood concentration, based on an in built pharmaco-kinetic data (TCI model) derived from previous studies. The TCI model also provides a real time predicted blood concentration to facilitate the anaesthetist to adjust the target concentration of propofol. The TCI algorithm is based on pharmaco-kinetic data derived from previous studies in a relatively small number of patients, by a "best fit" relationship between blood levels, infusion rates and other factors (such as age and weight). Several factors make it possible for a wide discrepancy between the predicted and the true blood concentrations. This difference can be higher in children compared to adults. Also blood loss and administration of large volumes of intravenous fluids can affect the blood concentrations. This study aims to identify the difference between the predicted and true blood concentrations by using Pelorus 1500, a bedside blood propofol measurement device, in children undergoing major spinal surgery under TIVA.